| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma, Neuroendocrine | D018278 | 2 associated lipids |
| Lymphatic Metastasis | D008207 | 10 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Cholesteatoma, Middle Ear | D018424 | 2 associated lipids |
| Tinea | D014005 | 5 associated lipids |
| Endotoxemia | D019446 | 27 associated lipids |
| Blister | D001768 | 16 associated lipids |
| Keratosis | D007642 | 9 associated lipids |
| Tularemia | D014406 | 3 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
HEMATOXYLIN
HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.
Cross Reference
Introduction
To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with HEMATOXYLIN?
HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN
PubChem Associated disorders and diseases
What pathways are associated with HEMATOXYLIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with HEMATOXYLIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
What genes are associated with HEMATOXYLIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with HEMATOXYLIN?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with HEMATOXYLIN
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Costa-Nogueira C et al. | Synthesis and expression of CDw75 antigen in human colorectal cancer. | 2009 | BMC Cancer | pmid:20003255 |
| Fritzsche FR et al. | ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. | 2008 | BMC Cancer | pmid:18582378 |
| Skandalis SS et al. | Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. | 2011 | BMC Cancer | pmid:21791066 |
| Zhang B et al. | Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. | 2009 | BMC Cancer | pmid:19995435 |
| El Khoury D et al. | Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. | 2010 | BMC Cancer | pmid:20573279 |
| Rubie C et al. | ELR+ CXC chemokine expression in benign and malignant colorectal conditions. | 2008 | BMC Cancer | pmid:18578857 |
| Ohri CM et al. | Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. | 2010 | BMC Cancer | pmid:20573209 |
| Kahlert C et al. | Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. | 2011 | BMC Cancer | pmid:21708005 |
| Jiang L et al. | Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. | 2010 | BMC Cancer | pmid:20569443 |
| Pinho SS et al. | Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. | 2007 | BMC Cancer | pmid:17617904 |
| de Kruijf EM et al. | NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. | 2012 | BMC Cancer | pmid:22257486 |
| Wang Q et al. | Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. | 2011 | BMC Cancer | pmid:21702992 |
| Gambichler T et al. | Pattern of mRNA expression of beta-defensins in basal cell carcinoma. | 2006 | BMC Cancer | pmid:16796735 |
| Chaube A et al. | Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. | 2006 | BMC Cancer | pmid:16686942 |
| Morgan K et al. | GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. | 2011 | BMC Cancer | pmid:22051164 |
| Hamtiaux L et al. | The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. | 2012 | BMC Cancer | pmid:22429826 |
| Kalinina T et al. | Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. | 2010 | BMC Cancer | pmid:20553613 |
| Mariani L et al. | Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. | 2010 | BMC Cancer | pmid:20525370 |
| Kim JH et al. | Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis. | 2010 | BMC Cancer | pmid:20509912 |
| Di Nicolantonio F et al. | Cancer cell adaptation to chemotherapy. | 2005 | BMC Cancer | pmid:16026610 |
| Egerod FL et al. | High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. | 2009 | BMC Cancer | pmid:19878561 |
| van Rossum AG et al. | Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. | 2006 | BMC Cancer | pmid:16536875 |
| Kalliomäki TM et al. | Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. | 2008 | BMC Cancer | pmid:18507854 |
| González-Reyes S et al. | Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. | 2010 | BMC Cancer | pmid:21129170 |
| Kratz JE et al. | Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. | 2002 | BMC Cancer | pmid:12460454 |
| Meyniel JP et al. | A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. | 2010 | BMC Cancer | pmid:20492709 |
| Chen M et al. | Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability. | 2011 | BMC Cancer | pmid:21612665 |
| Zhang D et al. | Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. | 2010 | BMC Cancer | pmid:21108842 |
| Nykopp TK et al. | Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. | 2009 | BMC Cancer | pmid:19435493 |
| Van Damme N et al. | Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. | 2010 | BMC Cancer | pmid:20459770 |
| Muinelo-Romay L et al. | Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer. | 2011 | BMC Cancer | pmid:22152070 |
| Walker LG et al. | Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer. | 2011 | BMC Cancer | pmid:21592370 |
| Ohri CM et al. | Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. | 2010 | BMC Cancer | pmid:20429924 |
| Kavanagh DO et al. | Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? | 2009 | BMC Cancer | pmid:19118499 |
| Tong QS et al. | BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. | 2004 | BMC Cancer | pmid:15248898 |
| Morrone FB et al. | In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. | 2006 | BMC Cancer | pmid:16995949 |
| Chanrion M et al. | A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. | 2007 | BMC Cancer | pmid:17338809 |
| Tuomela J et al. | Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts. | 2010 | BMC Cancer | pmid:21034500 |
| Nordfors K et al. | The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. | 2010 | BMC Cancer | pmid:20398423 |
| Valencia T et al. | Role and expression of FRS2 and FRS3 in prostate cancer. | 2011 | BMC Cancer | pmid:22078327 |
| Wu Z et al. | Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. | 2009 | BMC Cancer | pmid:19732464 |
| Lüchtenborg M et al. | Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. | 2005 | BMC Cancer | pmid:16356174 |
| Hadad SM et al. | Histological evaluation of AMPK signalling in primary breast cancer. | 2009 | BMC Cancer | pmid:19723334 |
| Brennan DJ et al. | Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. | 2010 | BMC Cancer | pmid:20359358 |
| Machado CM et al. | Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. | 2008 | BMC Cancer | pmid:18840301 |
| Sun S et al. | A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. | 2009 | BMC Cancer | pmid:19725976 |
| Nordentoft I et al. | Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. | 2011 | BMC Cancer | pmid:21489314 |
| ten Haaf A et al. | Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. | 2009 | BMC Cancer | pmid:19706168 |
| Roodink I et al. | Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. | 2009 | BMC Cancer | pmid:19703316 |
| Woelber L et al. | Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. | 2011 | BMC Cancer | pmid:21223596 |
| Deschoolmeester V et al. | Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. | 2010 | BMC Cancer | pmid:20346145 |
| Szybka M et al. | cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. | 2009 | BMC Cancer | pmid:19671129 |
| Shi H et al. | Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. | 2010 | BMC Cancer | pmid:20815902 |
| Kempkensteffen C et al. | Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. | 2009 | BMC Cancer | pmid:19664236 |
| Spindler KL et al. | EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. | 2011 | BMC Cancer | pmid:21439039 |
| Nykopp TK et al. | Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. | 2010 | BMC Cancer | pmid:20875124 |
| Gericke B et al. | Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. | 2005 | BMC Cancer | pmid:16225703 |
| Liu J et al. | Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. | 2009 | BMC Cancer | pmid:19653894 |
| Hung MS et al. | Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. | 2009 | BMC Cancer | pmid:19419583 |
| Aloysius MM et al. | Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? | 2010 | BMC Cancer | pmid:20202214 |
| Naguib A et al. | Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. | 2010 | BMC Cancer | pmid:20233436 |
| Lööf J et al. | Impact of PINCH expression on survival in colorectal cancer patients. | 2011 | BMC Cancer | pmid:21426571 |
| Van der Auwera I et al. | Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. | 2010 | BMC Cancer | pmid:20226036 |
| Nyalendo C et al. | Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. | 2009 | BMC Cancer | pmid:19961596 |
| Tomlinson VA et al. | Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. | 2005 | BMC Cancer | pmid:16156888 |
| Cheng Y et al. | Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. | 2007 | BMC Cancer | pmid:17927838 |
| Gockel I et al. | Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. | 2006 | BMC Cancer | pmid:17176471 |
| Ihnen M et al. | Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. | 2012 | BMC Cancer | pmid:22475274 |
| Papageorgiou KI and Kaniorou-Larai MG | A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment. | 2005 | BMC Cancer | pmid:16111484 |
| Mascolo M et al. | Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. | 2010 | BMC Cancer | pmid:20178651 |
| Zhao C et al. | Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. | 2009 | BMC Cancer | pmid:19586554 |
| Bedin V et al. | Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. | 2010 | BMC Cancer | pmid:20525386 |
| Graziano F et al. | Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. | 2001 | BMC Cancer | pmid:11518545 |
| Malfettone A et al. | Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. | 2012 | BMC Cancer | pmid:22439624 |
| Jörissen H et al. | Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. | 2009 | BMC Cancer | pmid:19552806 |
| Arellano-Llamas A et al. | High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. | 2006 | BMC Cancer | pmid:17067390 |
| Schneider M et al. | Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. | 2012 | BMC Cancer | pmid:22433494 |
| Lo Muzio L et al. | P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. | 2005 | BMC Cancer | pmid:15967043 |
| Genelhu MC et al. | A comparative study between mixed-type tumours from human salivary and canine mammary glands. | 2007 | BMC Cancer | pmid:18045453 |
| van Cruijsen H et al. | Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. | 2009 | BMC Cancer | pmid:19519895 |
| Sheahan S et al. | Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. | 2007 | BMC Cancer | pmid:18021445 |
| Dierssen JW et al. | High-resolution analysis of HLA class I alterations in colorectal cancer. | 2006 | BMC Cancer | pmid:17014712 |
| Fu J et al. | In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells. | 2011 | BMC Cancer | pmid:21649908 |
| He HT et al. | Siah1 proteins enhance radiosensitivity of human breast cancer cells. | 2010 | BMC Cancer | pmid:20682032 |
| Gonzalez LO et al. | Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. | 2008 | BMC Cancer | pmid:18507821 |
| Kumar MJ et al. | A mouse model for luminal epithelial like ER positive subtype of human breast cancer. | 2007 | BMC Cancer | pmid:17880731 |
| Seigne C et al. | Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. | 2010 | BMC Cancer | pmid:20663219 |
| Boström P et al. | MMP-1 expression has an independent prognostic value in breast cancer. | 2011 | BMC Cancer | pmid:21835023 |
| Fernández-Guinea O et al. | Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. | 2010 | BMC Cancer | pmid:20064215 |
| Keightley MC et al. | PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer. | 2010 | BMC Cancer | pmid:20840749 |
| Xiaorong L et al. | Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. | 2008 | BMC Cancer | pmid:18651974 |
| Zavagno G et al. | Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. | 2005 | BMC Cancer | pmid:15762990 |
| Wang J et al. | A reproducible brain tumour model established from human glioblastoma biopsies. | 2009 | BMC Cancer | pmid:20040089 |
| Romanucci M et al. | Heat shock protein expression in canine malignant mammary tumours. | 2006 | BMC Cancer | pmid:16803633 |
| Bacman D et al. | TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. | 2007 | BMC Cancer | pmid:17692120 |
| Toledo MT et al. | Cancer during pregnancy alters the activity of rat placenta and enhances the expression of cleaved PARP, cytochrome-c and caspase 3. | 2006 | BMC Cancer | pmid:16800886 |
| Mesquita B et al. | No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. | 2005 | BMC Cancer | pmid:16095531 |
| Wang J et al. | Case report: PET/CT, a cautionary tale. | 2007 | BMC Cancer | pmid:17683560 |
| Wu QW et al. | Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. | 2012 | BMC Cancer | pmid:22284579 |
| Macartney-Coxson DP et al. | Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. | 2008 | BMC Cancer | pmid:18590575 |